Human Immunodeficiency Virus

44
Saddam Ansari Tbilisi State Medical University Human Immunodeficiency Virus (HIV)

description

 

Transcript of Human Immunodeficiency Virus

Page 1: Human Immunodeficiency Virus

Saddam Ansari Tbilisi State Medical

University

Human Immunodeficiency Virus (HIV)

Page 2: Human Immunodeficiency Virus

IntroductionEtiologic agent of Acquired

Immunodeficiency Syndrome (AIDS).

Discovered independently by Luc Montagnier of France and Robert Gallo of the US in 1983-84.

Former names of the virus include:Human T cell lymphotrophic virus (HTLV-

III)Lymphadenopathy associated virus (LAV)AIDS associated retrovirus (ARV)

Page 3: Human Immunodeficiency Virus

IntroductionHIV-2 discovered in 1986, antigenically

distinct virus endemic in West Africa.

One million people infected in US, 30 million worldwide are infected.

Leading cause of death of men aged 25-44 and 4th leading cause of death of women in this age group in the US.

Page 4: Human Immunodeficiency Virus

Characteristics of the virusIcosahedral (20 sided), enveloped virus

of the lentivirus subfamily of retroviruses.

Retroviruses transcribe RNA to DNA.Two viral strands of RNA found in core

surrounded by protein outer coat.Outer envelope contains a lipid matrix within

which specific viral glycoproteins are imbedded.

These knob-like structures responsible for binding to target cell.

Page 5: Human Immunodeficiency Virus

Characteristics of the virus

Page 6: Human Immunodeficiency Virus

Structural GenesThree main structural genes:

Group Specific Antigen (Gag)Envelope (Env)Polymerase (Pol)

Page 7: Human Immunodeficiency Virus

Group Specific Antigen (Gag)Located in nucelocapsid of virus.Icosahedryl capsid surrounds the

internal nucleic acids made up of p24 andp15.

p17 lies between protein core and envelope and is embedded in the internal portion of the envelope.

Two additional p55 products, p7 and p9, are nucleic acid binding proteins closely associated with the RNA.

Page 8: Human Immunodeficiency Virus

Envelope (Env)Envelope (Env) gene codes for envelope proteins gp160, gp120 and gp41.

These polyproteins will eventually be cleaved by proteases to become HIV envelope glycoproteins gp120 and gp41.

gp160 cleaved to form gp120 and gp41.

gp120 forms the 72 knobs which protrude from outer envelope.

gp41 is a transmembrane glycoprotein antigen that spans the inner and outer membranes and attaches to gp120.

gp120 and gp41 both involved with fusion and attachment of HIV to CD4 antigen on host cells.

Page 9: Human Immunodeficiency Virus

Polymerase (Pol)Polymerase (Pol) codes for p66 and p51 subunits of reverse transcriptase and p31 an endonuclease.

Located in the core, close to nucleic acids.

Responsible for conversion of viral RNA into DNA, integration of DNA into host cell DNA and cleavage of protein precursors.

Page 10: Human Immunodeficiency Virus
Page 11: Human Immunodeficiency Virus

Viral ReplicationFirst step, HIV attaches to

susceptible host cell.Site of attachment is the CD4 antigen

found on a variety of cellshelper T cellsmacrophagesmonocytesB cellsmicroglial brain cellsintestinal cells

T cells infected later on.

Page 12: Human Immunodeficiency Virus

Early Phase HIV InfectionIn early phase HIV

infection, initial viruses are M-tropic. Their envelope glycoprotein gp120 is able to bind to CD4 molecules and chemokine receptors called CCR5 found on macrophages

Page 13: Human Immunodeficiency Virus

In late phase HIV infection, most of the viruses are T-tropic, having gp120 capable of binding to CD4 and CXCR4 found on T4-lymphocytes.

Page 14: Human Immunodeficiency Virus

Viral ReplicationThe gp120 protein on virus binds

specifically to CD4 receptor on host cell with high affinity.

Gp41 causes fusion of the virus to the cell membrane.After fusion virus particle enters cell.Viral genome exposed by uncoating particle.

Page 15: Human Immunodeficiency Virus

Viral ReplicationReverse transcriptase produces viral DNA from RNA.

Becomes a provirus which integrates into host DNA.

Period of latency occurs.

Page 16: Human Immunodeficiency Virus

Viral ReplicationAfter a period of latency lasting up to 10

years viral replication is triggered and occurs at high rate.

CD4 cell may be destroyed in the process, body attempts to replace lost CD4 cells, but over the course of many years body is unable to keep the count at a safe level.

Destruction of large numbers of CD4 cause symptoms of HIV to appear with increased susceptibility to opportunistic infections, disease and malignancy.

Page 17: Human Immunodeficiency Virus
Page 18: Human Immunodeficiency Virus

HIV (arrows) Infecting a T-lymphocyte

Page 19: Human Immunodeficiency Virus

Viral ReplicationMethods of transmission:

Sexual transmission, presence of STD increases likelihood of transmission.

Exposure to infected blood or blood products.Use of contaminated clotting factors by

hemophiliacs.Sharing contaminated needles (IV drug users).Transplantation of infected tissues or organs.Mother to fetus, perinatal transmission

variable, dependent on viral load and mother’s CD 4 count.

Page 20: Human Immunodeficiency Virus

Transmission

Page 21: Human Immunodeficiency Virus

Primary HIV SyndromeMononucleosis-like, cold or flu-like

symptoms may occur 6 to 12 weeks after infection.lymphadenopathyfeverrashheadacheFatiguediarrheasore throatneurologic manifestations.no symptoms (sometimes)

Page 22: Human Immunodeficiency Virus

Primary HIV SyndromeSymptoms are relatively nonspecific.HIV antibody test often negative but

becomes positive within 3 to 6 months, this process is known as seroconversion.

Large amount of HIV in the peripheral blood.

Primary HIV can be diagnosed using viral load titer assay or other tests.

Primary HIV syndrome resolves itself and HIV infected person remains asymptomatic for a prolonged period of time, often years.

Page 23: Human Immunodeficiency Virus

Clinical Latency PeriodHIV continues to reproduce, CD4 count

gradually declines from its normal value of 500-1200.

Once CD4 count drops below 500, HIV infected person at risk for opportunistic infections.

The following diseases are predictive of the progression to AIDS:persistent herpes-zoster infection (shingles)oral candidiasis (thrush)oral hairy leukoplakiaKaposi’s sarcoma (KS)

Page 24: Human Immunodeficiency Virus

Oral Candidiasis (thrush)

Page 25: Human Immunodeficiency Virus

Oral Hairy Leukoplakia

Being that HIV reduces immunologic activity, the intraoral environment is a prime target for chronic secondary infections and inflammatory processes, including OHL, which is due to the Epstein-Barr virus under immunosuppressed conditions

Page 26: Human Immunodeficiency Virus

Kaposi’s sarcoma (KS)Kaposi’s sarcoma

(shown) is a rare cancer of the blood vessels that is associated with HIV. It manifests as bluish-red oval-shaped patches that may eventually become thickened. Lesions may appear singly or in clusters.

Page 27: Human Immunodeficiency Virus

AIDSCD4 count drops below 200 person

is considered to have advanced HIV disease

If preventative medications not started the HIV infected person is now at risk for:Pneumocystis carinii pneumonia (PCP)cryptococcal meningitistoxoplasmosis

Page 28: Human Immunodeficiency Virus

Contined…If CD4 count drops below 50:

Mycobacterium aviumCytomegalovirus infectionslymphomadementiaMost deaths occur with CD4 counts below 50.

Page 29: Human Immunodeficiency Virus

Other Opportunistic InfectionsRespiratory system

Pneumocystis Carinii Pneumonia (PCP) Tuberculosis (TB)Kaposi's Sarcoma (KS)

Gastro-intestinal systemCryptosporidiosisCandidaCytomegolavirus (CMV)Isosporiasis Kaposi's Sarcoma

Page 30: Human Immunodeficiency Virus

Continued…Central/peripheral Nervous system

CytomegolavirusToxoplasmosisCryptococcosisNon Hodgkin's lymphomaVaricella ZosterHerpes simplex

Skin Herpes simpleKaposi's sarcomaVaricella Zoster

Page 31: Human Immunodeficiency Virus

Infants with HIVFailure to thrivePersistent oral candidiasisHepatosplenomegalyLymphadenopathyRecurrent diarrheaRecurrent bacterial infectionsAbnormal neurologic findings.

Page 32: Human Immunodeficiency Virus

Immunologic ManifestationsEarly stage slight depression of CD4 count,

few symptoms, temporary.

Window of up to 6 weeks before antibody is detected, by 6 months 95% positive.

During window p24 antigen present, acute viremia and antigenemia.

Page 33: Human Immunodeficiency Virus

Immunologic ManifestationsAntibodies produced to all major antigens.

First antibodies detected produced against gag proteins p24 and p55.

Followed by antibody to p51, p120 and gp41

As disease progresses antibody levels decrease.

Page 34: Human Immunodeficiency Virus

Immunologic ManifestationsImmune abnormalities associated with

increased viral replication.Decrease in CD4 cells due to virus budding from

cells, fusion of uninfected cells with virally infected cells and apoptosis.

B cells have decreased response to antigens possibly due to blockage of T cell/B cell interaction by binding of viral proteins to CD4 site.

CD8 cells initially increase and may remain elevated.

As HIV infection progresses, CD4 T cells drop resulting in immunosuppression and susceptibility of patient to opportunistic infections.

Death comes due to immuno-incompetence.

Page 35: Human Immunodeficiency Virus

Immunologic ManifestationsImmune abnormalities associated with

increased viral replication.Decrease in CD4 cells due to virus budding from

cells, fusion of uninfected cells with virally infected cells and apoptosis.

B cells have decreased response to antigens possibly due to blockage of T cell/B cell interaction by binding of viral proteins to CD4 site.

CD8 cells initially increase and may remain elevated.

As HIV infection progresses, CD4 T cells drop resulting in immunosuppression and susceptibility of patient to opportunistic infections.

Death comes due to immuno-incompetence.

Page 36: Human Immunodeficiency Virus

Laboratory Diagnosis of HIV InfectionMethods utilized to detect:

AntibodyAntigenViral nucleic acidVirus in culture

Page 37: Human Immunodeficiency Virus

Western BlotMost popular confirmatory test.

Utilizes a lysate prepared from HIV virus.The lysate is electrophoresed to separate out

the HIV proteins (antigens).The paper is cut into strips and reacted with

test sera.After incubation and washing anti-antibody

tagged with radioisotope or enzyme is added.Specific bands form where antibody has

reacted with different antigens.Most critical reagent of test is purest quality

HIV antigen.The following antigens must be present: p17,

p24, p31, gp41, p51, p55, p66, gp120 and gp160.

Page 38: Human Immunodeficiency Virus

Western BlotAntibodies to p24 and p55 appear earliest

but decrease or become undetectable.Antibodies to gp31, gp41, gp 120, and

gp160 appear later but are present throughout all stages of the disease.

Page 39: Human Immunodeficiency Virus

Western BlotInterpretation of results.

No bands, negative.In order to be interpreted as positive a

minimum of 3 bands directed against the following antigens must be present: p24, p31, gp41 or gp120/160.

CDC criteria require 2 bands of the following: p24, gp41 or gp120/160.

Page 40: Human Immunodeficiency Virus

DNA PCRDNA PCRRNA PCRRNA PCR

p24 Agp24 Ag3rd gen ELISA1st gen ELISA

Detuned ELISA1wk 2wk 3wk 2mo 6mo 1yr 2yr 3yr +8yr

gp160gp120

p68p55p53

gp41-45

p40

p34

p24

p18

p12

gp160gp120

p68p55p53

gp41-45

p40

p34

p24

p18

p12

gp160gp120

p68p55p53

gp41-45

p40

p34

p24

p18

p12

early recent / established advanced

Spectrum Spectrum of anti-HIV of anti-HIV

testing testing

Page 41: Human Immunodeficiency Virus

Western BlotIndeterminate results are those samples that

produce bands but not enough to be positive, may be due to the following:prior blood transfusions, even with non-HIV-1 infected

bloodprior or current infection with syphilisprior or current infection with malariaautoimmune diseases (e.g., diabetes, Grave’s disease,

etc)infection with other human retrovirusessecond or subsequent pregnancies in women.run an alternate HIV confirmatory assay.

Quality control of Western Blot is critical and requires testing with strongly positive, weakly positive and negative controls.

Page 42: Human Immunodeficiency Virus

Testing of NeonatesDifficult due to presence of maternal IgG

antibodies.Use tests to detect IgM or IgA antibodies,

IgM lacks sensitivity, IgA more promising.Measurement of p24 antigen.PCR testing may be helpful but still not

detecting antigen soon enough: 38 days to 6 months to be positive.

Page 43: Human Immunodeficiency Virus

The Move Toward Lower Pill BurdensDosing Daily pill burdenRegimen

1996

Zerit/Epivir/Crixivan 10 pills, Q8H

20023 pills, BIDCombivir (AZT/3TC)/EFV

1998Retrovir/Epivir/Sustiva 5 pills, BID

20033 pills, QDViread/ Emtriva/Sustiva

20042 pills, QDTruvada/Sustiva

Page 44: Human Immunodeficiency Virus